Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...

The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control ...

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

Drugmakers like Glenmark Pharma and its peers continue to benefit from strong domestic demand for their speciality drugs and those used for treating ... Nordisk says it is gradually phasing out human ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

From what is understood, the campaign aligns with the International Diabetes Federation’s theme of "Diabetes and Well-being.

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...